Although normal hepatocytes do not express the IGF-1 receptor (IGF-1R), hepatic non-parenchymal cells do express IGF-1R [28,44], and IGF-1 affects multiple pathways relevant to NASH pathogenesis. Here, IGF1 is linked to metabolic dysfunction-associated steatohepatitis.